A61K 31/4433
Containing a six-membered ring with oxygen as a ring hetero atom
Official title: containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4433 (Containing a six-membered ring with oxygen as a ring hetero atom) appears on 343 US grants and 592 published applications in this corpus.
Search patents in A61K- Granted patents
- 343
- Published applications
- 592
- Assignees
- 302
- Inventors
- 1,689
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 5 | 7 |
| 2003 | 7 | 13 |
| 2004 | 3 | 15 |
| 2005 | 3 | 13 |
| 2006 | 3 | 20 |
| 2007 | 5 | 13 |
| 2008 | 4 | 9 |
| 2009 | 1 | 10 |
| 2010 | 5 | 14 |
| 2011 | 7 | 21 |
| 2012 | 7 | 18 |
| 2013 | 20 | 29 |
| 2014 | 25 | 36 |
| 2015 | 22 | 38 |
| 2016 | 31 | 24 |
| 2017 | 34 | 37 |
| 2018 | 20 | 31 |
| 2019 | 27 | 39 |
| 2020 | 26 | 36 |
| 2021 | 23 | 26 |
| 2022 | 16 | 22 |
| 2023 | 10 | 23 |
| 2024 | 12 | 32 |
| 2025 | 8 | 44 |
| 2026 | 6 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase23 Jun 2026US 12,661,342 B2Gt Gain Therapeutics SA
- Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient21 Apr 2026US 12,605,358 B2Aliad Biopharma
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and pharmaceutical use therefor21 Apr 2026US 12,605,359 B2Lipoprotein Research Stockholm AB
- 3-phenylpropylamine derivative21 Apr 2026US 12,606,533 B2Daiichi Sankyo Company, Limited
- Methods of treating cancer with an mTOR inhibitor3 Feb 2026US 12,539,305 B2Revolution Medicines, Inc.
- Therapy based on synthetic lethality in swi/snf complex-dysfunction cancer27 Aug 2026US 2026/0248806 A1National Cancer Center
- Antimalarial endoperoxide derivatives for the treatment of myelodyplastic syndrome20 Aug 2026US 2026/0242391 A1The Scripps Research Institute
- Novel decursin derivative and use thereof for preventing or treating non-small cell lung cancer13 Aug 2026US 2026/0232625 A1Jaein R&P Inc.
- Amide compounds as activators of the potassium channels kv7.2/kv7.3 useful in the treatment of cns and pns disorders6 Aug 2026US 2026/0226007 A1Angelini Pharma S.P.A.
- Thiochroman derivative and preparation method therefor and use thereof6 Aug 2026US 2026/0226035 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Most cited
By later US patents
- Aryl- or heteroaryl-substituted benzene compounds82US 8,410,088 B2Eisai R&D Management Co., Ltd. · 2013
- C-glycoside derivatives and salts thereof74US 7,202,350 B2Astellas Pharma Inc. · 2007
- Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity68US 5,602,130 AAllergan, Inc. · 1997
- Self-emulsifying formulation for lipophilic compounds61US 6,531,139 B1Pharmacia & Upjohn Company · 2003
- Aryl- or heteroaryl-substituted benzene compounds59US 8,765,732 B2Epizyme, Inc. · 2014